Back to Startups

Adaptamtx

Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
@Adaptamtx Website LinkedIn Madrid
About Adaptamtx

A company pioneering cancer immunotherapies specifically targeting immunosuppressive myeloid cells.

Business Information
Target Customers
hospitals oncologists research institutions
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model B2B
Pricing Strategy N/A
Sales Channels direct sales, partnerships with healthcare providers
Funding Timeline
Round Date Amount Investors
Pre-Seed Oct 27, 2025 $3.0M Criteria Bio Ventures
Founders

No founder information available.

Investors
C
Criteria Bio Ventures

Venture Capital

Recent Mentions
EU_Startups
EU-Startups @EU_Startups
Oct 27, 2025

Spain's @Adaptamtx, a company pioneering #cancer immunotherapies specifically targeting immunosuppressive myeloid cells, has raised a €3 million #preSeed financing round 🇪🇸 🎗 https://t.co/O9bt9p3W2Q

View on Twitter
menlotimes
Menlo Times @menlotimes
Oct 28, 2025

Based in Bilbao 🇪🇸, Adaptam just raised €3M pre-seed led by Criteria Bio Ventures to advance its first-in-class antibody programs, spanning ADCs and bispecifics, targeting glyco-immune checkpoints on myeloid cells. These cells, especially tumor-associated macrophages (TAMs),

View on Twitter
Similar Startups
Adaptam Therapeutics
93% match

Adaptam Therapeutics is a biotechnology startup focused on developing innovative antibody-based ther...
Odyssey_Tx
89% match

Precision immunomodulators for oncology and immunity
Avammune Therapeutics
88% match

Avammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and de...
Tcelltech
88% match

Tcelltech is a clinical-stage biopharma focused on developing immunotherapies, particularly a univer...